BlackRock Health Sciences Term Trust (NYSE:BMEZ - Get Free Report) major shareholder Saba Capital Management, L.P. bought 15,455 shares of the firm's stock in a transaction that occurred on Thursday, September 19th. The shares were purchased at an average cost of 16.14 per share, for a total transaction of 249,443.70. Following the purchase, the insider now owns 20,601,568 shares in the company, valued at approximately 332,509,307.52. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Major shareholders that own 10% or more of a company's shares are required to disclose their sales and purchases with the SEC.
Saba Capital Management, L.P. also recently made the following trade(s):
- On Tuesday, September 17th, Saba Capital Management, L.P. purchased 27,148 shares of BlackRock Health Sciences Term Trust stock. The shares were acquired at an average price of 15.93 per share, for a total transaction of 432,467.64.
BlackRock Health Sciences Term Trust Price Performance
NYSE BMEZ opened at 16.02 on Tuesday. The firm has a 50 day simple moving average of 15.85 and a 200-day simple moving average of 15.55. BlackRock Health Sciences Term Trust has a one year low of 12.93 and a one year high of 16.59.
BlackRock Health Sciences Term Trust Announces Dividend
[Urgent!] Web3 Could Send One Crypto Soaring
From Crypto 101 Media | Ad
Venture Capital corporations and blockchain funds are pouring money into Web3 gaming.And there's one little-known crypto coin that's poised for RAPID growth as we see Web3 expand over the next few years.
Click here to review my research and unique strategy to score potential profits from this under-the-
The firm also recently declared a monthly dividend, which will be paid on Thursday, October 31st. Shareholders of record on Tuesday, October 15th will be paid a $0.176 dividend. The ex-dividend date of this dividend is Tuesday, October 15th. This represents a $2.11 annualized dividend and a dividend yield of 13.18%.
Institutional Trading of BlackRock Health Sciences Term Trust
A number of large investors have recently modified their holdings of the stock. Sanctuary Advisors LLC acquired a new position in BlackRock Health Sciences Term Trust during the 2nd quarter worth $3,179,000. Quarry LP boosted its stake in shares of BlackRock Health Sciences Term Trust by 304.9% in the 2nd quarter. Quarry LP now owns 98,886 shares of the company's stock valued at $1,519,000 after buying an additional 74,463 shares during the period. Almitas Capital LLC grew its position in shares of BlackRock Health Sciences Term Trust by 89.3% during the second quarter. Almitas Capital LLC now owns 1,761,943 shares of the company's stock worth $27,063,000 after buying an additional 831,025 shares in the last quarter. Sessa Capital IM L.P. increased its stake in shares of BlackRock Health Sciences Term Trust by 27.1% during the second quarter. Sessa Capital IM L.P. now owns 1,853,022 shares of the company's stock worth $28,462,000 after buying an additional 395,288 shares during the period. Finally, Logan Stone Capital LLC acquired a new stake in BlackRock Health Sciences Term Trust in the second quarter valued at approximately $1,770,000.
About BlackRock Health Sciences Term Trust
BlackRock Health Sciences Trust II’s (BMEZ) (the 'Trust') investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Featured Stories
- Five stocks we like better than BlackRock Health Sciences Term Trust
- Best Aerospace Stocks Investing
- The Average 401k Balance by Age Explained
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- When to Sell a Stock for Profit or Loss
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [emailprotected].
Insider Buying or Selling at BlackRock Health Sciences Term Trust?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for BlackRock Health Sciences Term Trust and related companies.
More From MarketBeat
